Abstract:Abstract Background: More than one-third of all U.S. adults are obese (BMI >30); and 15% of middle-aged adults, the group most commonly diagnosed and treated for colorectal and other cancers, meet the criteria for class II obesity (BMI> = 35). In contrast to the large and consistent body of evidence for obesity and increased colorectal cancer risk, several recent meta-analyses indicate that the association with colorectal patient survival is poorly defined. Some evidence suggests that moderate adiposity may be protective. In a prospective cohort of well-characterized CRC patients, we evaluated class I and class II obesity in relation to 5-year and 10-year survival outcomes. Methods: Histologically-confirmed colorectal adenocarcinoma patients (n = 634) evaluated at the University of Texas MD Anderson Cancer Center were followed for a median period of 4 years. We collected epidemiological data through questionnaires and abstracted treatment, anthropometric, and clinicopathologic data from patients’ electronic medical records. Overall survival (OS) and progression/recurrence-free survival (PFS) were calculated from the date of pathologic diagnosis until disease progression, first recurrence, or death. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in multivariable Cox proportional hazards models adjusted for demographics, lifestyle factors, tumor characteristics, and treatment modality. Results: We observed a 1.5-fold increased risk of death among class II obese (BMI> = 35), as compared to overweight CRC patients in multivariable-adjusted models. Among patients who reported stable weight and among stage I-III patients, the association between class II obesity and OS was more pronounced [BMI> = 35 vs. BMI 25-29.9 (ref), HR and 95% CI: 3.49 (1.68-7.22) and 2.40 (1.33-4.31), respectively], but no associations were observed among metastatic patients or among patients who experienced recent weight loss. Similar associations were observed with PFS, but few reached statistical significance. Conclusions: Severe adiposity defined as class II obesity (BMI > = 35) was associated with significantly higher mortality among CRC patients. Clarifying what is not a healthy weight for cancer patients and survivors remains both a clinically relevant and timely concern. Understanding and targeting this relationship may improve long-term outcomes among growing numbers of obese patients and cancer survivors. Citation Format: Carrie R. Daniel, Xiang Shu, Yuanqing Ye, Jian Gu, G. S. Raju, Scott Kopetz, Xifeng Wu. Severe obesity and colorectal cancer patient survival. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3737. doi:10.1158/1538-7445.AM2015-3737

Association between long-term energy balance-related factors and survival in colorectal cancer overall and by metabolic Warburg-subtypes

Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status

Prediagnosis Body Mass Index and Waist–hip Circumference Ratio in Association with Colorectal Cancer Survival

Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype

The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach

Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies

Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis

Excess adiposity and survival in patients with colorectal cancer: a systematic review

The Impact of Body Mass Index and Waist Circumference on Health-related Quality of Life Among Colorectal Cancer Survivors: Results from the PROFILES Registry

Abstract 3737: Severe Obesity and Colorectal Cancer Patient Survival

Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population

The impact of body mass index on prognosis in patients with colon carcinoma

The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis

Investigating the Obesity Paradox in Colorectal Cancer: An Analysis of Prospectively Collected Data in a Diverse Cohort

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Associations of postdiagnosis changes in physical activity with all-cause mortality among patients with stage I-IIA colorectal cancer.

Body Mass Index and Molecular Subtypes of Colorectal Cancer.

Associations of the dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations with patient-reported outcomes in colorectal cancer survivors 2–10 years post-diagnosis: a cross-sectional analysis

Post‐diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer

Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis